image credit: Freepik

BriaCell Awarded Research Grant from Wiseman Cancer Research Foundation

September 4, 2020

Via: BioSpace

BriaCell Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is announcing that it has received a research grant from the Wiseman Cancer Research Foundation, a 501c(3) nonprofit organization based in Beverly Hills, CA. The research grants are awarded to individual scientists or entities that pursue outstanding research in immuno-oncology. Dr. Charles L. Wiseman, BriaCell’s Scientific Founder and Director, currently serves as President of the Wiseman Cancer Research Foundation.

“We are grateful for the support that we have received from the Wiseman Cancer Research Foundation, and are honored to have received the award,” said Dr. Bill Williams, BriaCell’s President and CEO.

Read More on BioSpace